We provide you with 20 years of free, institutional-grade data for SLNO stock, allowing you to gain comprehensive visibility into the fundamentals of the company. This in-depth information is essential for making informed investment decisions and understanding the financial health and performance of SLNO. Explore the full financial landscape of SLNO stock.
| Reported Date | CIK | Ticker | Type | |
|---|---|---|---|---|
| 2025-08-06 | 0001484565 | SLNO | 10-Q | Url |
| 2025-05-07 | 0001484565 | SLNO | 10-Q | Url |
| 2025-02-28 | 0001484565 | SLNO | 10-K | Url |
| 2024-11-06 | 0001484565 | SLNO | 10-Q | Url |
| 2024-08-07 | 0001484565 | SLNO | 10-Q | Url |
| 2024-05-09 | 0001484565 | SLNO | 10-Q | Url |
| 2024-03-07 | 0001484565 | SLNO | 10-K | Url |
| 2023-11-08 | 0001484565 | SLNO | 10-Q | Url |
| 2023-08-08 | 0001484565 | SLNO | 10-Q | Url |
| 2023-07-21 | 0001484565 | SLNO | S-1 | Url |
| 2023-05-09 | 0001484565 | SLNO | 10-Q | Url |
| 2023-03-22 | 0001484565 | SLNO | 10-K | Url |
| 2022-11-09 | 0001484565 | SLNO | 10-Q | Url |
| 2022-08-10 | 0001484565 | SLNO | 10-Q | Url |
| 2022-05-10 | 0001484565 | SLNO | 10-Q | Url |
| 2022-03-31 | 0001484565 | SLNO | 10-K | Url |
| 2021-11-10 | 0001484565 | SLNO | 10-Q | Url |
| 2021-07-28 | 0001484565 | SLNO | 10-Q | Url |
| 2021-05-05 | 0001484565 | SLNO | 10-Q | Url |
| 2021-03-03 | 0001484565 | SLNO | 10-K | Url |
| 2020-11-10 | 0001484565 | SLNO | 10-Q | Url |
| 2020-08-10 | 0001484565 | SLNO | 10-Q | Url |
| 2020-05-12 | 0001484565 | SLNO | 10-Q | Url |
| 2020-03-04 | 0001484565 | SLNO | 10-K | Url |
| 2019-11-13 | 0001484565 | SLNO | 10-Q | Url |
| 2019-08-07 | 0001484565 | SLNO | 10-Q | Url |
| 2019-05-13 | 0001484565 | SLNO | 10-Q | Url |
| 2019-03-29 | 0001484565 | SLNO | S-1 | Url |
| 2019-03-20 | 0001484565 | SLNO | 10-K | Url |
| 2018-11-14 | 0001484565 | SLNO | 10-Q | Url |
| 2018-08-14 | 0001484565 | SLNO | 10-Q | Url |
| 2018-05-15 | 0001484565 | SLNO | 10-Q | Url |
| 2018-04-02 | 0001484565 | SLNO | 10-K | Url |
| 2018-01-29 | 0001484565 | SLNO | S-1 | Url |
| 2017-11-14 | 0001484565 | SLNO | 10-Q | Url |
| 2017-08-11 | 0001484565 | SLNO | 10-Q | Url |
| 2017-05-11 | 0001484565 | SLNO | 10-Q | Url |
| 2017-04-21 | 0001484565 | SLNO | S-1 | Url |
| 2017-03-15 | 0001484565 | SLNO | 10-K | Url |
| 2017-02-01 | 0001484565 | SLNO | S-1 | Url |
| 2016-11-14 | 0001484565 | SLNO | 10-Q | Url |
| 2016-08-12 | 0001484565 | SLNO | 10-Q | Url |
| 2016-07-12 | 0001484565 | SLNO | S-1 | Url |
| 2016-05-12 | 0001484565 | SLNO | 10-Q | Url |
| 2016-03-25 | 0001484565 | SLNO | 10-K | Url |
| 2015-11-19 | 0001484565 | SLNO | S-1 | Url |
| 2015-11-12 | 0001484565 | SLNO | 10-Q | Url |
| 2015-08-10 | 0001484565 | SLNO | 10-Q | Url |
| 2015-08-04 | 0001484565 | SLNO | S-1 | Url |
| 2015-05-04 | 0001484565 | SLNO | 10-Q | Url |
| 2015-05-04 | 0001484565 | SLNO | S-1 | Url |
| 2015-03-13 | 0001484565 | SLNO | 10-K | Url |
| 2014-12-18 | 0001484565 | SLNO | 10-Q | Url |
| 2014-06-10 | 0001484565 | SLNO | S-1 | Url |
Soleno Therapeutics, Inc(NASDAQ:SLNO) 
Soleno Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of novel therapeutics for the treatment of rare diseases. Its lead candidate is Diazoxide Choline Controlled-Release (DCCR), a once-daily oral tablet for the treatment of Prader-Wi...
Website: http://www.soleno.life
Founded: 1999
Full Time Employees: 13
Sector: Healthcare
Industry: Diagnostics & Research
The information provided in this report about SLNO stock is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.